Verrica Pharmaceuticals (VRCA) Change in Acquisitions & Divestments (2019 - 2022)

Verrica Pharmaceuticals' Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $7.0 million for Q4 2022.

• In Q4 2022, Change in Acquisitions & Divestments fell 50.7% year-over-year to $7.0 million; the TTM figure through Sep 2023 stood at $7.0 million (down 89.43% YoY), while the FY2022 annual figure was $59.0 million, down 14.48% from the prior year.
• Change in Acquisitions & Divestments for Q4 2022 stood at $7.0 million, up from $2.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $47.5 million in Q1 2022, with the low at $2.0 million in Q3 2022.
• The 4-year median for Change in Acquisitions & Divestments is $19.6 million (2020), against an average of $19.7 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 131.75% in 2022, while the deepest fall reached 89.54% in 2022.
• Verrica Pharmaceuticals' Change in Acquisitions & Divestments stood at $24.5 million in 2019, then slumped by 50.61% to $12.1 million in 2020, then grew by 17.36% to $14.2 million in 2021, then plunged by 50.7% to $7.0 million in 2022.
• Business Quant data shows VRCA's Change in Acquisitions & Divestments at $7.0 million in Q4 2022, $2.0 million in Q3 2022, and $2.5 million in Q2 2022.